1 |
94-26-8 |
ABAT |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of ABAT mRNA |
affects^cotreatment|increases^expression |
25607892 |
2 |
94-26-8 |
ACAN |
Mus musculus |
butylparaben results in decreased expression of ACAN mRNA |
decreases^expression |
28527915 |
3 |
94-26-8 |
ACTN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ACTN1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
4 |
94-26-8 |
ADAM17 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ADAM17 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
5 |
94-26-8 |
ADAM17 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of ADAM17 mRNA |
affects^cotreatment|increases^expression |
25607892 |
6 |
94-26-8 |
ADIPOQ |
Homo sapiens |
butylparaben results in increased expression of ADIPOQ mRNA |
increases^expression |
22956630 |
7 |
94-26-8 |
ADIPOQ |
Mus musculus |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of ADIPOQ mRNA] |
decreases^reaction|increases^expression |
22956630 |
8 |
94-26-8 |
ADIPOQ |
Mus musculus |
2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of ADIPOQ mRNA] |
decreases^reaction|increases^expression |
22956630 |
9 |
94-26-8 |
ADIPOQ |
Mus musculus |
butylparaben promotes the reaction [Dexamethasone results in increased expression of ADIPOQ mRNA] |
increases^expression|increases^reaction |
22956630 |
10 |
94-26-8 |
ADIPOQ |
Mus musculus |
Mifepristone inhibits the reaction [butylparaben results in increased expression of ADIPOQ mRNA] |
decreases^reaction|increases^expression |
22956630 |
11 |
94-26-8 |
ALPL |
Mus musculus |
butylparaben results in decreased expression of ALPL mRNA |
decreases^expression |
28527915 |
12 |
94-26-8 |
ALPL |
Mus musculus |
NR3C1 protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA] |
decreases^expression|increases^reaction |
28527915 |
13 |
94-26-8 |
ALPL |
Mus musculus |
PPARG protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA] |
decreases^expression|increases^reaction |
28527915 |
14 |
94-26-8 |
AR |
Rattus norvegicus |
butylparaben binds to AR protein |
affects^binding |
20371976 |
15 |
94-26-8 |
AR |
|
[butylparaben co-treated with propylparaben] promotes the reaction [isobutyl-4-hydroxybenzoate inhibits the reaction [Metribolone results in increased activity of AR protein]] |
affects^cotreatment|decreases^reaction|increases^activity|increases^reaction |
20132345 |
16 |
94-26-8 |
BDNF |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of BDNF mRNA |
affects^cotreatment|decreases^expression |
25607892 |
17 |
94-26-8 |
BGLAP |
Mus musculus |
butylparaben results in decreased expression of BGLAP mRNA |
decreases^expression |
28527915 |
18 |
94-26-8 |
BSN |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of BSN mRNA |
affects^cotreatment|decreases^expression |
25607892 |
19 |
94-26-8 |
CACNA1A |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1A mRNA |
affects^cotreatment|increases^expression |
25607892 |
20 |
94-26-8 |
CACNA1C |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA1C mRNA |
affects^cotreatment|affects^expression |
25607892 |
21 |
94-26-8 |
CACNA1C |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1C mRNA |
affects^cotreatment|decreases^expression |
25607892 |
22 |
94-26-8 |
CACNA1D |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CACNA1D mRNA |
affects^cotreatment|increases^expression |
25607892 |
23 |
94-26-8 |
CACNA1D |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1D mRNA |
affects^cotreatment|increases^expression |
25607892 |
24 |
94-26-8 |
CACNA1E |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1E mRNA |
affects^cotreatment|decreases^expression |
25607892 |
25 |
94-26-8 |
CACNA1F |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1F mRNA |
affects^cotreatment|decreases^expression |
25607892 |
26 |
94-26-8 |
CACNA1G |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1G mRNA |
affects^cotreatment|decreases^expression |
25607892 |
27 |
94-26-8 |
CACNA1G |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA1G mRNA |
affects^cotreatment|increases^expression |
25607892 |
28 |
94-26-8 |
CACNA1H |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA1H mRNA |
affects^cotreatment|decreases^expression |
25607892 |
29 |
94-26-8 |
CACNA1I |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNA1I mRNA |
affects^cotreatment|decreases^expression |
25607892 |
30 |
94-26-8 |
CACNA2D1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CACNA2D1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
31 |
94-26-8 |
CACNA2D1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNA2D1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
32 |
94-26-8 |
CACNA2D2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CACNA2D2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
33 |
94-26-8 |
CACNA2D2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA2D2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
34 |
94-26-8 |
CACNA2D3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] affects the expression of CACNA2D3 mRNA |
affects^cotreatment|affects^expression |
25607892 |
35 |
94-26-8 |
CACNA2D3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNA2D3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
36 |
94-26-8 |
CACNB1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNB1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
37 |
94-26-8 |
CACNB2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNB2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
38 |
94-26-8 |
CACNB2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNB2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
39 |
94-26-8 |
CACNB3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CACNB3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
40 |
94-26-8 |
CACNB3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNB3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
41 |
94-26-8 |
CACNG2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of CACNG2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
42 |
94-26-8 |
CACNG5 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNG5 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
43 |
94-26-8 |
CACNG6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CACNG6 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
44 |
94-26-8 |
CACNG6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNG6 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
45 |
94-26-8 |
CACNG8 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CACNG8 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
46 |
94-26-8 |
CAMK2B |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CAMK2B mRNA |
affects^cotreatment|increases^expression |
25607892 |
47 |
94-26-8 |
CASK |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CASK mRNA |
affects^cotreatment|affects^expression |
25607892 |
48 |
94-26-8 |
CASK |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CASK mRNA |
affects^cotreatment|decreases^expression |
25607892 |
49 |
94-26-8 |
CCND1 |
Homo sapiens |
butylparaben results in increased expression of CCND1 mRNA |
increases^expression |
23524099 |
50 |
94-26-8 |
CD44 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CD44 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
51 |
94-26-8 |
CD44 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CD44 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
52 |
94-26-8 |
CEBPA |
Homo sapiens |
butylparaben results in increased expression of CEBPA mRNA |
increases^expression |
22956630 |
53 |
94-26-8 |
CEBPA |
Mus musculus |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] |
decreases^reaction|increases^expression |
22956630 |
54 |
94-26-8 |
CEBPA |
Mus musculus |
2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] |
decreases^reaction|increases^expression |
22956630 |
55 |
94-26-8 |
CEBPA |
Mus musculus |
butylparaben promotes the reaction [Dexamethasone results in increased expression of CEBPA mRNA] |
increases^expression|increases^reaction |
22956630 |
56 |
94-26-8 |
CEBPA |
Mus musculus |
Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] |
decreases^reaction|increases^expression |
22956630 |
57 |
94-26-8 |
CEBPA |
Mus musculus |
PPARG protein promotes the reaction [butylparaben results in increased expression of CEBPA mRNA] |
increases^expression|increases^reaction |
28527915 |
58 |
94-26-8 |
CEBPA |
Mus musculus |
rimonabant inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] |
decreases^reaction|increases^expression |
27659731 |
59 |
94-26-8 |
CHRDL1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CHRDL1 mRNA |
affects^cotreatment|affects^expression |
25607892 |
60 |
94-26-8 |
CNTN3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN3 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
61 |
94-26-8 |
CNTN4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of CNTN4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
62 |
94-26-8 |
COL10A1 |
Mus musculus |
butylparaben results in decreased expression of COL10A1 mRNA |
decreases^expression |
28527915 |
63 |
94-26-8 |
COL2A1 |
Mus musculus |
butylparaben results in decreased expression of COL2A1 mRNA |
decreases^expression |
28527915 |
64 |
94-26-8 |
COPS2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of COPS2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
65 |
94-26-8 |
CYP11B1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of CYP11B1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
66 |
94-26-8 |
CYP17A1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP17A1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
67 |
94-26-8 |
CYP19A1 |
Homo sapiens |
butylparaben results in decreased expression of CYP19A1 mRNA |
decreases^expression |
23744433 |
68 |
94-26-8 |
CYP19A1 |
Homo sapiens |
butylparaben results in decreased expression of CYP19A1 protein |
decreases^expression |
23744433 |
69 |
94-26-8 |
CYP19A1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CYP19A1 mRNA |
affects^cotreatment|affects^expression |
25607892 |
70 |
94-26-8 |
CYP19A1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of CYP19A1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
71 |
94-26-8 |
CYP1A1 |
Homo sapiens |
[butylparaben co-treated with triclocarban] results in increased expression of CYP1A1 mRNA |
affects^cotreatment|increases^expression |
23524099 |
72 |
94-26-8 |
CYP1A1 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP1A1 protein |
decreases^activity |
27432241 |
73 |
94-26-8 |
CYP1A2 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP1A2 protein |
decreases^activity |
27432241 |
74 |
94-26-8 |
CYP1B1 |
Homo sapiens |
butylparaben promotes the reaction [bisphenol A results in increased expression of CYP1B1 mRNA] |
increases^expression|increases^reaction |
23524099 |
75 |
94-26-8 |
CYP1B1 |
Homo sapiens |
butylparaben results in increased expression of CYP1B1 mRNA |
increases^expression |
23524099 |
76 |
94-26-8 |
CYP2B1 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP2B1 protein |
decreases^activity |
27432241 |
77 |
94-26-8 |
CYP2C11 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP2C11 protein |
decreases^activity |
27432241 |
78 |
94-26-8 |
CYP2E1 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP2E1 protein |
decreases^activity |
27432241 |
79 |
94-26-8 |
CYP3A62 |
Rattus norvegicus |
butylparaben results in decreased activity of CYP3A62 protein |
decreases^activity |
27432241 |
80 |
94-26-8 |
DCC |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DCC mRNA |
affects^cotreatment|decreases^expression |
25607892 |
81 |
94-26-8 |
DLG1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of DLG1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
82 |
94-26-8 |
DLG4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DLG4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
83 |
94-26-8 |
DLG4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of DLG4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
84 |
94-26-8 |
DLG4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of DLG4 mRNA |
affects^cotreatment|increases^expression |
25607892 |
85 |
94-26-8 |
DLGAP3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of DLGAP3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
86 |
94-26-8 |
DLGAP3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of DLGAP3 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
87 |
94-26-8 |
DNMT3A |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of DNMT3A mRNA |
affects^cotreatment|decreases^expression |
25607892 |
88 |
94-26-8 |
DPP6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of DPP6 mRNA |
affects^cotreatment|increases^expression |
25607892 |
89 |
94-26-8 |
EGF |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of EGF mRNA |
affects^cotreatment|decreases^expression |
25607892 |
90 |
94-26-8 |
ERBB2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ERBB2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
91 |
94-26-8 |
ERBB3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ERBB3 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
92 |
94-26-8 |
ERBB3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of ERBB3 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
93 |
94-26-8 |
ERBB4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of ERBB4 mRNA |
affects^cotreatment|affects^expression |
25607892 |
94 |
94-26-8 |
ERBB4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ERBB4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
95 |
94-26-8 |
ERBB4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of ERBB4 mRNA |
affects^cotreatment|increases^expression |
25607892 |
96 |
94-26-8 |
ERBB4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of ERBB4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
97 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben binds to and results in increased activity of ESR1 protein |
affects^binding|increases^activity |
20362049|20435135|23567241|25012808 |
98 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben binds to ESR1 protein |
affects^binding |
11193391|19063592|20074635 |
99 |
94-26-8 |
ESR1 |
Homo sapiens |
[butylparaben co-treated with NRG1 protein] promotes the reaction [ESR1 protein binds to MYC enhancer] |
affects^binding|affects^cotreatment|increases^reaction |
26502914 |
100 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben results in decreased activity of ESR1 protein |
decreases^activity |
25012808 |
101 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben results in decreased expression of ESR1 mRNA |
decreases^expression |
23524099 |
102 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben results in increased activity of ESR1 protein |
increases^activity |
22562034 |
103 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben results in increased expression of ESR1 mRNA |
increases^expression |
25128701 |
104 |
94-26-8 |
ESR1 |
Homo sapiens |
butylparaben results in increased expression of ESR1 protein |
increases^expression |
25128701 |
105 |
94-26-8 |
ESR1 |
Homo sapiens |
fulvestrant inhibits the reaction [butylparaben results in increased activity of ESR1 protein] |
decreases^reaction|increases^activity |
22562034 |
106 |
94-26-8 |
ESR1 |
Rattus norvegicus |
butylparaben inhibits the reaction [Estradiol binds to ESR1 protein] |
affects^binding|decreases^reaction |
15204698 |
107 |
94-26-8 |
ESR1 |
Rattus norvegicus |
butylparaben results in decreased expression of ESR1 protein |
decreases^expression |
19654335 |
108 |
94-26-8 |
ESR1 |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in decreased expression of ESR1 mRNA] |
decreases^expression|decreases^reaction |
19654335 |
109 |
94-26-8 |
ESR1 |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in decreased expression of ESR1 protein] |
decreases^expression|decreases^reaction |
19654335 |
110 |
94-26-8 |
ESR2 |
Homo sapiens |
butylparaben binds to and results in increased activity of ESR2 protein |
affects^binding|increases^activity |
23567241 |
111 |
94-26-8 |
ESR2 |
Homo sapiens |
butylparaben binds to ESR2 protein |
affects^binding |
11193391 |
112 |
94-26-8 |
ESR2 |
Homo sapiens |
butylparaben results in increased expression of ESR2 mRNA |
increases^expression |
25128701 |
113 |
94-26-8 |
ESR2 |
Homo sapiens |
butylparaben results in increased expression of ESR2 protein |
increases^expression |
25128701 |
114 |
94-26-8 |
ESR2 |
Rattus norvegicus |
butylparaben results in decreased expression of ESR2 mRNA |
decreases^expression |
18648085 |
115 |
94-26-8 |
ESRRG |
Homo sapiens |
butylparaben inhibits the reaction [afimoxifene inhibits the reaction [ESRRG protein binds to NCOA2 protein]] |
affects^binding|decreases^reaction |
23583298 |
116 |
94-26-8 |
FAAH |
Homo sapiens |
butylparaben results in decreased activity of FAAH protein |
decreases^activity |
27659731 |
117 |
94-26-8 |
FABP4 |
Homo sapiens |
butylparaben results in increased expression of FABP4 mRNA |
increases^expression |
22956630 |
118 |
94-26-8 |
FABP4 |
Mus musculus |
butylparaben promotes the reaction [Dexamethasone results in increased expression of FABP4 mRNA] |
increases^expression|increases^reaction |
22956630 |
119 |
94-26-8 |
FABP4 |
Mus musculus |
NR3C1 protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA] |
increases^expression|increases^reaction |
28527915 |
120 |
94-26-8 |
FABP4 |
Mus musculus |
PPARG mutant form inhibits the reaction [butylparaben results in increased expression of FABP4 mRNA] |
decreases^reaction|increases^expression |
22956630 |
121 |
94-26-8 |
FABP4 |
Mus musculus |
PPARG protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA] |
increases^expression|increases^reaction |
28527915 |
122 |
94-26-8 |
FASN |
Homo sapiens |
butylparaben results in increased expression of FASN mRNA |
increases^expression |
22956630 |
123 |
94-26-8 |
FASN |
Mus musculus |
butylparaben promotes the reaction [Dexamethasone results in increased expression of FASN mRNA] |
increases^expression|increases^reaction |
22956630 |
124 |
94-26-8 |
FGFR1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
125 |
94-26-8 |
FGFR2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of FGFR2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
126 |
94-26-8 |
FYN |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of FYN mRNA |
affects^cotreatment|affects^expression |
25607892 |
127 |
94-26-8 |
GABRA4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GABRA4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
128 |
94-26-8 |
GABRB1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GABRB1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
129 |
94-26-8 |
GLS |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GLS mRNA |
affects^cotreatment|decreases^expression |
25607892 |
130 |
94-26-8 |
GLS |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GLS mRNA |
affects^cotreatment|decreases^expression |
25607892 |
131 |
94-26-8 |
GPER1 |
Homo sapiens |
butylparaben results in increased expression of GPER1 mRNA |
increases^expression |
26253279 |
132 |
94-26-8 |
GPER1 |
Homo sapiens |
butylparaben results in increased expression of GPER1 protein |
increases^expression |
26253279 |
133 |
94-26-8 |
GRIA2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GRIA2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
134 |
94-26-8 |
GRIA4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GRIA4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
135 |
94-26-8 |
GRIA4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GRIA4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
136 |
94-26-8 |
GRIK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GRIK2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
137 |
94-26-8 |
GRIK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIK2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
138 |
94-26-8 |
GRIK4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GRIK4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
139 |
94-26-8 |
GRIK5 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIK5 mRNA |
affects^cotreatment|increases^expression |
25607892 |
140 |
94-26-8 |
GRIN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of GRIN1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
141 |
94-26-8 |
GRIN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIN1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
142 |
94-26-8 |
GRIN2B |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GRIN2B mRNA |
affects^cotreatment|decreases^expression |
25607892 |
143 |
94-26-8 |
GRIN2C |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GRIN2C mRNA |
affects^cotreatment|decreases^expression |
25607892 |
144 |
94-26-8 |
GRIN2D |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GRIN2D mRNA |
affects^cotreatment|decreases^expression |
25607892 |
145 |
94-26-8 |
GRIN2D |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of GRIN2D mRNA |
affects^cotreatment|increases^expression |
25607892 |
146 |
94-26-8 |
GRIN3A |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of GRIN3A mRNA |
affects^cotreatment|decreases^expression |
25607892 |
147 |
94-26-8 |
GRIP1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of GRIP1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
148 |
94-26-8 |
HES6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of HES6 mRNA |
affects^cotreatment|increases^expression |
25607892 |
149 |
94-26-8 |
HR |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of HR mRNA |
affects^cotreatment|decreases^expression |
25607892 |
150 |
94-26-8 |
HSD17B10 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of HSD17B10 mRNA |
affects^cotreatment|increases^expression |
25607892 |
151 |
94-26-8 |
HSD17B8 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of HSD17B8 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
152 |
94-26-8 |
HSD3B6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of HSD3B6 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
153 |
94-26-8 |
HSPB8 |
Homo sapiens |
butylparaben results in increased expression of HSPB8 mRNA |
increases^expression |
23524099 |
154 |
94-26-8 |
IGF1R |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of IGF1R mRNA |
affects^cotreatment|increases^expression |
25607892 |
155 |
94-26-8 |
IGF2R |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of IGF2R mRNA |
affects^cotreatment|decreases^expression |
25607892 |
156 |
94-26-8 |
IL1RAPL1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of IL1RAPL1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
157 |
94-26-8 |
JAG1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of JAG1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
158 |
94-26-8 |
LEP |
Homo sapiens |
butylparaben results in decreased expression of LEP mRNA |
decreases^expression |
22956630 |
159 |
94-26-8 |
LEP |
Mus musculus |
butylparaben results in increased expression of LEP mRNA |
increases^expression |
22956630 |
160 |
94-26-8 |
LIN7A |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of LIN7A mRNA |
affects^cotreatment|increases^expression |
25607892 |
161 |
94-26-8 |
LPIN1 |
Mus musculus |
butylparaben results in increased expression of LPIN1 mRNA |
increases^expression |
22956630 |
162 |
94-26-8 |
LPIN1 |
Mus musculus |
[Dexamethasone co-treated with butylparaben] results in increased expression of LPIN1 mRNA |
affects^cotreatment|increases^expression |
22956630 |
163 |
94-26-8 |
LPIN1 |
Mus musculus |
NR3C1 mutant form inhibits the reaction [butylparaben results in increased expression of LPIN1 mRNA] |
decreases^reaction|increases^expression |
22956630 |
164 |
94-26-8 |
MAGI2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of MAGI2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
165 |
94-26-8 |
MAGI2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MAGI2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
166 |
94-26-8 |
MDGA2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of MDGA2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
167 |
94-26-8 |
MDGA2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MDGA2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
168 |
94-26-8 |
MET |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of MET mRNA |
affects^cotreatment|increases^expression |
25607892 |
169 |
94-26-8 |
MMP3 |
Rattus norvegicus |
[enzacamene co-treated with octylmethoxycinnamate co-treated with bisphenol A co-treated with butylparaben] results in increased expression of MMP3 mRNA |
affects^cotreatment|increases^expression |
25305543 |
170 |
94-26-8 |
MYC |
Homo sapiens |
butylparaben promotes the reaction [NRG1 protein results in increased expression of MYC mRNA] |
increases^expression|increases^reaction |
26502914 |
171 |
94-26-8 |
MYC |
Homo sapiens |
butylparaben results in increased expression of MYC mRNA |
increases^expression |
26502914 |
172 |
94-26-8 |
MYC |
Homo sapiens |
[NRG1 protein co-treated with butylparaben] results in increased expression of MYC protein |
affects^cotreatment|increases^expression |
26502914 |
173 |
94-26-8 |
MYC |
Homo sapiens |
NRG1 protein promotes the reaction [butylparaben results in increased expression of MYC mRNA] |
increases^expression|increases^reaction |
26502914 |
174 |
94-26-8 |
NF1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NF1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
175 |
94-26-8 |
NF1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NF1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
176 |
94-26-8 |
NLGN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NLGN1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
177 |
94-26-8 |
NLGN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NLGN1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
178 |
94-26-8 |
NLGN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NLGN1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
179 |
94-26-8 |
NOTCH2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
180 |
94-26-8 |
NOTCH2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NOTCH2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
181 |
94-26-8 |
NOTCH4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NOTCH4 mRNA |
affects^cotreatment|increases^expression |
25607892 |
182 |
94-26-8 |
NOTCH4 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NOTCH4 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
183 |
94-26-8 |
NR1I2.L |
Xenopus laevis |
butylparaben binds to and results in increased activity of NR1I2.L protein |
affects^binding|increases^activity |
12198127 |
184 |
94-26-8 |
NR1I2.S |
Xenopus laevis |
butylparaben binds to and results in increased activity of NR1I2.S protein |
affects^binding|increases^activity |
12198127 |
185 |
94-26-8 |
NR3C1 |
Homo sapiens |
[butylparaben co-treated with propylparaben] results in increased activity of NR3C1 protein |
affects^cotreatment|increases^activity |
25448277 |
186 |
94-26-8 |
NR3C1 |
Homo sapiens |
butylparaben results in increased activity of NR3C1 protein |
increases^activity |
25448277 |
187 |
94-26-8 |
NR3C1 |
Homo sapiens |
[Diethylhexyl Phthalate co-treated with butylparaben co-treated with propylparaben] results in increased activity of NR3C1 protein |
affects^cotreatment|increases^activity |
25448277 |
188 |
94-26-8 |
NR3C1 |
Homo sapiens |
[Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin co-treated with propylparaben] results in increased activity of NR3C1 protein |
affects^cotreatment|increases^activity |
25448277 |
189 |
94-26-8 |
NR3C1 |
Homo sapiens |
[Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin] results in increased activity of NR3C1 protein |
affects^cotreatment|increases^activity |
25448277 |
190 |
94-26-8 |
NR3C1 |
Homo sapiens |
[Diethylhexyl Phthalate co-treated with butylparaben] results in increased activity of NR3C1 protein |
affects^cotreatment|increases^activity |
25448277 |
191 |
94-26-8 |
NR3C1 |
Mus musculus |
NR3C1 protein promotes the reaction [butylparaben results in decreased expression of SPP1 mRNA] |
decreases^expression|increases^reaction |
28527915 |
192 |
94-26-8 |
NR3C1 |
Mus musculus |
NR3C1 protein promotes the reaction [butylparaben results in increased expression of PLIN1 mRNA] |
increases^expression|increases^reaction |
28527915 |
193 |
94-26-8 |
NR3C1 |
Mus musculus |
NR3C1 protein results in increased susceptibility to butylparaben |
increases^response to substance |
28527915 |
194 |
94-26-8 |
NR3C1 |
|
butylparaben promotes the reaction [Dexamethasone results in increased expression of NR3C1 mRNA] |
increases^expression|increases^reaction |
22956630 |
195 |
94-26-8 |
NR3C2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NR3C2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
196 |
94-26-8 |
NR5A1 |
Rattus norvegicus |
butylparaben results in decreased expression of NR5A1 mRNA |
decreases^expression |
27122241 |
197 |
94-26-8 |
NRCAM |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRCAM mRNA |
affects^cotreatment|increases^expression |
25607892 |
198 |
94-26-8 |
NRG1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NRG1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
199 |
94-26-8 |
NRG1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRG1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
200 |
94-26-8 |
NRXN1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
201 |
94-26-8 |
NRXN2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NRXN2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
202 |
94-26-8 |
NRXN2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NRXN2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
203 |
94-26-8 |
NTRK1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NTRK1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
204 |
94-26-8 |
NTRK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of NTRK2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
205 |
94-26-8 |
NTRK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NTRK2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
206 |
94-26-8 |
NTRK3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of NTRK3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
207 |
94-26-8 |
NTRK3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of NTRK3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
208 |
94-26-8 |
NXPH3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of NXPH3 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
209 |
94-26-8 |
PGR |
Homo sapiens |
butylparaben results in increased expression of PGR mRNA |
increases^expression |
23524099|25128701 |
210 |
94-26-8 |
PGR |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of PGR mRNA |
affects^cotreatment|decreases^expression |
25607892 |
211 |
94-26-8 |
PGR |
Rattus norvegicus |
butylparaben results in increased expression of PGR protein |
increases^expression |
19654335 |
212 |
94-26-8 |
PGR |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in increased expression of PGR mRNA] |
decreases^reaction|increases^expression |
19654335 |
213 |
94-26-8 |
PGR |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in increased expression of PGR protein] |
decreases^reaction|increases^expression |
19654335 |
214 |
94-26-8 |
PLIN1 |
Mus musculus |
butylparaben results in increased expression of PLIN1 mRNA |
increases^expression |
22956630 |
215 |
94-26-8 |
PLIN1 |
Mus musculus |
PPARG mutant form inhibits the reaction [butylparaben results in increased expression of PLIN1 mRNA] |
decreases^reaction|increases^expression |
22956630 |
216 |
94-26-8 |
PLIN1 |
Mus musculus |
PPARG protein promotes the reaction [butylparaben results in increased expression of PLIN1 mRNA] |
increases^expression|increases^reaction |
28527915 |
217 |
94-26-8 |
PPARG |
Homo sapiens |
butylparaben binds to and results in increased activity of PPARG protein |
affects^binding|increases^activity |
24155963 |
218 |
94-26-8 |
PPARG |
Homo sapiens |
butylparaben results in increased expression of PPARG mRNA |
increases^expression |
22956630 |
219 |
94-26-8 |
PPARG |
Mus musculus |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] |
decreases^reaction|increases^expression |
22956630 |
220 |
94-26-8 |
PPARG |
Mus musculus |
2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] |
decreases^reaction|increases^expression |
22956630 |
221 |
94-26-8 |
PPARG |
Mus musculus |
butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA] |
increases^expression|increases^reaction |
22956630 |
222 |
94-26-8 |
PPARG |
Mus musculus |
butylparaben results in increased activity of PPARG protein |
increases^activity |
28527915 |
223 |
94-26-8 |
PPARG |
Mus musculus |
Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA] |
decreases^reaction|increases^expression |
22956630 |
224 |
94-26-8 |
PPARG |
Mus musculus |
PPARG protein inhibits the reaction [butylparaben results in decreased expression of SPP1 mRNA] |
decreases^expression|decreases^reaction |
28527915 |
225 |
94-26-8 |
PPARG |
Mus musculus |
PPARG protein promotes the reaction [butylparaben binds to and results in increased activity of PPARG protein] |
affects^binding|increases^activity|increases^reaction |
24155963 |
226 |
94-26-8 |
PPARG |
Mus musculus |
PPARG protein results in increased susceptibility to butylparaben |
increases^response to substance |
28527915 |
227 |
94-26-8 |
PRKN |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of PRKN mRNA |
affects^cotreatment|decreases^expression |
25607892 |
228 |
94-26-8 |
PRKN |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of PRKN mRNA |
affects^cotreatment|decreases^expression |
25607892 |
229 |
94-26-8 |
RELN |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of RELN mRNA |
affects^cotreatment|decreases^expression |
25607892 |
230 |
94-26-8 |
ROBO1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of ROBO1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
231 |
94-26-8 |
RUNX2 |
Mus musculus |
butylparaben results in decreased expression of RUNX2 mRNA |
decreases^expression |
28527915 |
232 |
94-26-8 |
S100G |
Rattus norvegicus |
butylparaben results in increased expression of S100G mRNA |
increases^expression |
19654335 |
233 |
94-26-8 |
S100G |
Rattus norvegicus |
butylparaben results in increased expression of S100G protein |
increases^expression |
19654335 |
234 |
94-26-8 |
S100G |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in increased expression of S100G mRNA] |
decreases^reaction|increases^expression |
19654335 |
235 |
94-26-8 |
S100G |
Rattus norvegicus |
fulvestrant inhibits the reaction [butylparaben results in increased expression of S100G protein] |
decreases^reaction|increases^expression |
19654335 |
236 |
94-26-8 |
SHANK1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SHANK1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
237 |
94-26-8 |
SHANK1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SHANK1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
238 |
94-26-8 |
SHANK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of SHANK2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
239 |
94-26-8 |
SHANK2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of SHANK2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
240 |
94-26-8 |
SHANK3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SHANK3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
241 |
94-26-8 |
SLC17A7 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC17A7 mRNA |
affects^cotreatment|increases^expression |
25607892 |
242 |
94-26-8 |
SLC1A1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
243 |
94-26-8 |
SLC1A2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
244 |
94-26-8 |
SLC1A3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
245 |
94-26-8 |
SLC1A3 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLC1A3 mRNA |
affects^cotreatment|increases^expression |
25607892 |
246 |
94-26-8 |
SLC1A6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of SLC1A6 mRNA |
affects^cotreatment|increases^expression |
25607892 |
247 |
94-26-8 |
SLIT1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of SLIT1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
248 |
94-26-8 |
SLIT1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SLIT1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
249 |
94-26-8 |
SPP1 |
Mus musculus |
butylparaben results in decreased expression of SPP1 mRNA |
decreases^expression |
28527915 |
250 |
94-26-8 |
SPTBN2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of SPTBN2 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
251 |
94-26-8 |
STAR |
Rattus norvegicus |
butylparaben results in decreased expression of STAR mRNA |
decreases^expression |
18648085 |
252 |
94-26-8 |
STMN2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STMN2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
253 |
94-26-8 |
STS |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of STS mRNA |
affects^cotreatment|decreases^expression |
25607892 |
254 |
94-26-8 |
STS |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of STS mRNA |
affects^cotreatment|decreases^expression |
25607892 |
255 |
94-26-8 |
STX1B |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STX1B mRNA |
affects^cotreatment|increases^expression |
25607892 |
256 |
94-26-8 |
STXBP1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of STXBP1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
257 |
94-26-8 |
STXBP1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of STXBP1 mRNA |
affects^cotreatment|increases^expression |
25607892 |
258 |
94-26-8 |
SYNGAP1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of SYNGAP1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
259 |
94-26-8 |
SYP |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of SYP mRNA |
affects^cotreatment|increases^expression |
25607892 |
260 |
94-26-8 |
SYT6 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of SYT6 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
261 |
94-26-8 |
TFF1 |
Homo sapiens |
butylparaben results in increased expression of TFF1 mRNA |
increases^expression |
16797915|22562034|23524099 |
262 |
94-26-8 |
TFF1 |
Homo sapiens |
fulvestrant inhibits the reaction [butylparaben results in increased expression of TFF1 mRNA] |
decreases^reaction|increases^expression |
22562034 |
263 |
94-26-8 |
TGFB1 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of TGFB1 mRNA |
affects^cotreatment|decreases^expression |
25607892 |
264 |
94-26-8 |
TSC2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of TSC2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
265 |
94-26-8 |
TSC2 |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of TSC2 mRNA |
affects^cotreatment|increases^expression |
25607892 |
266 |
94-26-8 |
TSNAX |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of TSNAX mRNA |
affects^cotreatment|decreases^expression |
25607892 |
267 |
94-26-8 |
TSPO |
Rattus norvegicus |
butylparaben results in decreased expression of TSPO mRNA |
decreases^expression |
18648085 |
268 |
94-26-8 |
UGT2B15 |
Homo sapiens |
butylparaben results in increased expression of UGT2B15 mRNA |
increases^expression |
23524099 |
269 |
94-26-8 |
UNC5A |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of UNC5A mRNA |
affects^cotreatment|decreases^expression |
25607892 |
270 |
94-26-8 |
UNC5B |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in decreased expression of UNC5B mRNA |
affects^cotreatment|decreases^expression |
25607892 |
271 |
94-26-8 |
UNC5C |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of UNC5C mRNA |
affects^cotreatment|increases^expression |
25607892 |
272 |
94-26-8 |
UNC5C |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] results in increased expression of UNC5C mRNA |
affects^cotreatment|increases^expression |
25607892 |
273 |
94-26-8 |
VEGFA |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in increased expression of VEGFA mRNA |
affects^cotreatment|increases^expression |
25607892 |
274 |
94-26-8 |
VLDLR |
Rattus norvegicus |
[bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben co-treated with Androgen Antagonists co-treated with Acetaminophen] results in decreased expression of VLDLR mRNA |
affects^cotreatment|decreases^expression |
25607892 |